{
    "title": "US FDA approves Novo Nordisk's therapy for rare genetic condition",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12585121/US-FDA-approves-Novo-Nordisks-therapy-rare-genetic-condition.html",
    "date": "2023-10-02",
    "keywords": [
        "therapy",
        "condition",
        "oxalate",
        "drug",
        "kidney",
        "value",
        "nordisk",
        "monday",
        "food",
        "administration",
        "fda",
        "injection",
        "brand",
        "name",
        "rivfloza",
        "use",
        "type",
        "function",
        "drugmaker",
        "access",
        "buyout",
        "interference",
        "technology",
        "novo",
        "year",
        "price",
        "benefit",
        "hyperoxaluria",
        "recurrent",
        "bladder",
        "liver",
        "enough",
        "protein",
        "production",
        "chemical",
        "alnylam",
        "oxlumo",
        "health",
        "treatment",
        "approval",
        "excretion",
        "baseline",
        "company",
        "roy",
        "bengaluru",
        "editing",
        "kalluvila",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}